IL-17A expression had a decreasing trend in both the ‘Chlamydia only’ and ‘Chlamydia and KoRV’ vaccine groups, with this trend becoming statistically significant 3–6 months post-vaccination and more so > 6 months post-vaccination ( Fig. 4 A).
← all excerpts
Reduction of <i>Chlamydia pecorum</i> and Koala Retrovirus subtype B expression in wild koalas vaccinated with novel peptide and peptide/recombinant protein formulations.
1
—
—